DENMARK – Denmark-based bioproduction company 21st.Bio is granting access to its precision fermentation platform to food and beverage ingredient manufacturers.

The platform aims to enable the cost-competitive production of dairy proteins through precision fermentation.

This move comes on the heels of the successful scaling of beta-lactoglobulin protein, a major component of milk with significant nutritional and textural benefits.

By widely offering its platform, 21st.Bio intends to reduce the cost and time associated with development, making proven industrial-scale production technology for alternative protein precision fermentation accessible.

The platform provides a sustainable and less resource-intensive alternative to traditional animal-based production methods, contributing to stabilizing global food supply chains.

Customers utilizing the platform will have access to industrial production strains, fermentation processes, scale-up support, and technology transfers to contract manufacturers, along with regulatory approvals for faster time-to-market and reduced costs.

The technology foundation is licensed from Novonesis (formerly Novozymes), a company with 40 years of experience in optimizing production strains and processes for industrial production.

The technology is already employed to produce numerous food-grade products on the market. 21st.Bio consistently optimizes strains and processes to keep customers ahead of market demands.

The precision fermentation technology platform can be tailored for specific purposes, such as nutritional fortification of plant-based products, texture improvement in alternative dairy, and medical nutrition.

This offering caters to both start-ups planning to bring proteins to market and established players expanding into sustainable alternatives or seeking to meet the growing global demand for proteins while minimizing environmental impact.

Thomas Schmidt, CEO of 21st.Bio, emphasized the company’s mission to make precision fermentation technology accessible to as many companies as possible.

“We believe this is the best way for technology to support and accelerate the transition to more sustainable and better nutrition globally. With this new offering, I am proud that companies will be able to safely scale innovation into industrial production and meet global demand utilising our technology and expertise,” he said.

“This initiative aligns with the goal of supporting the transition to more sustainable and better nutrition globally.”

Schmidt expressed pride in enabling companies to scale innovation into industrial production and meet global demand using the 21st. Bio’s technology and expertise.

Subscribe to our food and agriculture industry email newsletters that provide busy executives like you with the latest news insights and trends from Africa and the World. SUBSCRIBE HERE